added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to Outperform from Perform, citing a favorable valuation setup ahead of a mid-stage trial readout for its eczema ...

“But I felt very uncomfortable with a few scenes, such as the trial of Oppenheimer in the United States at the end.” The film quickly became a global hit after opening in the United States ...